Clinical Nutrition Notes

Dr. Emmanuel, MD reviews several common G.I. conditions that gastroenterologists and dietitians encounter in daily practice. The nutrition implications of irritable bowel syndrome (IBS), constipation, fecal incontinence and gastroparesis are explored in this episode.

Dr. Emmanuel, MD talks about enteral nutrition intolerance in a two-part series. In this second episode, enteral intolerance management strategies are discussed.

Dr. Emmanuel, MD talks about enteral nutrition intolerance in a two-part series. In this first episode, enteral intolerance is defined, and the assessment of gastrointestinal symptoms are explored.

Peter Lam, RD speaks about dysphagia in the older adult in this two-part series. In this second episode, Peter focuses on dysphagia screening, assessment and management considerations for clinicians – including the use of texture modified diets and thickened liquids.

Peter Lam, RD speaks about dysphagia in the older adult in this two-part series. In this first episode dysphagia is defined, its prevalence and presentation discussed, and common challenges related to dysphagia are reviewed.

Michele ApSimon, RD, reviews the evolution of evidence supporting the nutrition management of critically ill patients and the impact this emerging data is having on her ICU nutrition practice. Protein provision is a priority for many of her patients and use of specialized enteral nutrition formulas help meet protein needs and manage blood glucose levels.

Stuart Phillips, PhD, discusses current concepts in protein for the older critically ill patient. Changes in protein balance with aging and illness that present a particular challenge for the older patient are reviewed along with interventions to attenuate muscle loss, including attention to protein dose, source and quality.

Todd Rice, MD, speaks about glucose management in the ICU, the results of the Dietary management of glucose Variability in the ICU trial (DIVINE trial), and the evolving role of nutrition to help manage hyperglycemia in critical illness. He describes the DIVINE trial as a turning point in ICU nutrition research that has had an impact on his practice.